Octagon Therapeutics Company Profile, Contacts & Intelligence
Biotechnology ResearchProvidence, Rhode Island, United States7 employeesFounded 2017
2 contacts with email or phone data2 with email data1 with phone data
Employees
7
Company source estimate
Reachable Contacts
2
Visible contacts with email or phone data
Contacts With Email
2
2 of 4 visible contacts
Departments
2
Mapped contact coverage
Octagon Therapeutics Overview
Octagon is developing new medicines for autoimmune and inflammatory disease. The company is pioneering a selective immunomodulation approach based on glyco-immune checkpoint receptors that allows for precise targeting of disease-driving immune processes.
- Headquarters
- Providence, Rhode Island, United States
- Website
- octagontx.com
- Industry
- Biotechnology Research
- Founded
- 2017
- NAICS
- Research and Development in Biotechnology (except Nanobiotechnology)
- Phone Number
- Available in AeroLeads
- Company Email
- Available in AeroLeads
Octagon Therapeutics Contact Intelligence
See which contact channels and departments are represented in the visible AeroLeads data.
2 contacts with contact data
2 with email data and 1 with phone data in the visible sample.
2 departments represented
Visible contacts with email or phone data are mapped to these departments.
3 company-domain emails
Visible contacts using Octagon Therapeutics's company email domain.
Octagon Therapeutics People & Org Chart Preview
Sample people records show job titles and whether email or phone data is available without exposing raw contact details.
Octagon Therapeutics Workforce Composition
Seniority breakdown across 7 visible profiles.
Octagon Therapeutics Technology & Talent
Technology-related job titles represented in the visible people data.
Compare Similar Companies to Octagon Therapeutics
Explore companies in related markets and compare their industry and employee estimates.
| Company | Industry / match | Employee estimate | Page |
|---|---|---|---|
| Vertex Pharmaceuticals | Biotechnology Research | 6.09K | View company |
| Alnylam Pharmaceuticals | Biotechnology Research | 2.58K | View company |
| Tessera Therapeutics | Biotechnology Research | 326 | View company |
| Foghorn Therapeutics Inc. | Biotechnology Research | 125 | View company |
| Thrive Bioscience, Inc. | Biotechnology Research | 36 | View company |
| Slater Technology Fund | Venture Capital And Private Equity Principals | 23 | View company |
| Simcha Therapeutics | Biotechnology Research | 15 | View company |
| Seranova Bio | Biotechnology Research | 8 | View company |
| Stipple Bio | Biotechnology Research | 6 | View company |
| Bolden Therapeutics | Biotechnology Research | 3 | View company |